Literature DB >> 15224345

Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.

Eriko Fujimoto1, Haruna Satoh, Etsuko Negishi, Koichi Ueno, Yoji Nagashima, Kiyokazu Hagiwara, Hiroshi Yamasaki, Tomohiro Yano.   

Abstract

Connexin (Cx) genes have negative growth effects on tumor cells with certain cell specificity. We have previously reported that Cx32 is specifically downregulated in human renal cell carcinoma cell (RCC) lines as well as cancerous regions of kidneys and that the Cx is expressed in the progenitor cells of the carcinoma. However, the precise role of Cx32 in growth control of RCC cells remains unknown. In this study, we examined whether Cx32 could act in growth control against a human RCC cell, Caki-2 cell. In order to estimate the cell growth control, we established Caki-2 cells that have stable expression of Cx32 genes. Cx32 expression in Caki-2 cells induced contact inhibition of growth and reduced anchorage-independent growth ability, but did not significantly affect lag phase growth rates. This growth control by Cx32 was dependent on the inhibition of the cell-cycle transition from G1 to S phase at high cell density, and the inhibition of the cell-cycle transition related to the suppression of Her-2 activation. Furthermore, the suppression of Cx32 expression in Caki-2 cells by short interfering RNA induced the activation of Her-2. These data suggest that Cx32 has negative growth control of Caki-2 cells, partly due to the inhibition of the Her-2 activation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224345     DOI: 10.1002/mc.20025

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

Review 1.  Gap junctional communication in morphogenesis.

Authors:  Michael Levin
Journal:  Prog Biophys Mol Biol       Date:  2007-03-16       Impact factor: 3.667

Review 2.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

3.  Connexin 32 overexpression increases proliferation, reduces gap junctional intercellular communication, motility and epithelial-to-mesenchymal transition in Hs578T breast cancer cells.

Authors:  Deniz Ugur; Taha Bugra Gungul; Simge Yucel; Engin Ozcivici; Ozden Yalcin-Ozuysal; Gulistan Mese
Journal:  J Cell Commun Signal       Date:  2022-07-04       Impact factor: 5.908

4.  Role of connexin 43 in Helicobacter pylori VacA-induced cell death.

Authors:  Jana N Radin; Christian González-Rivera; Arwen E Frick-Cheng; Jinsong Sheng; Jennifer A Gaddy; Donald H Rubin; Holly M Scott Algood; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

Review 5.  Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene.

Authors:  H Sato; H Hagiwara; Y Ohde; H Senba; N Virgona; T Yano
Journal:  J Membr Biol       Date:  2007-06-13       Impact factor: 1.843

6.  5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.

Authors:  H Hagiwara; H Sato; Y Ohde; Y Takano; T Seki; T Ariga; N Hokaiwado; M Asamoto; T Shirai; Y Nagashima; T Yano
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 7.  Connexins in Cancer: Jekyll or Hyde?

Authors:  Erin E Mulkearns-Hubert; Ofer Reizes; Justin D Lathia
Journal:  Biomolecules       Date:  2020-12-10

Review 8.  The stage-specific function of gap junctions during tumourigenesis.

Authors:  Jarosław Czyz
Journal:  Cell Mol Biol Lett       Date:  2007-10-29       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.